- Home
- JBI vs FDMT Comparison
JBI vs FDMT Comparison
Compare JBI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBI | FDMT |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 728.3M | 695.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | JBI | FDMT |
|---|---|---|
| Price | $5.31 | $10.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $9.17 | ★ $31.71 |
| AVG Volume (30 Days) | ★ 1.2M | 868.4K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | $9.36 | N/A |
| Revenue Next Year | $3.16 | $70.28 |
| P/E Ratio | $12.96 | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $4.26 | $4.27 |
| 52 Week High | $10.80 | $14.00 |
Technical Indicators
Market Signals| Indicator | JBI | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 40.73 |
| Support Level | $4.89 | $9.71 |
| Resistance Level | $5.50 | $10.50 |
| Average True Range (ATR) | 0.15 | 0.79 |
| MACD | -0.01 | -0.30 |
| Stochastic Oscillator | 58.47 | 9.04 |
Price Performance
Historical ComparisonAbout JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. It provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).